A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisine in Adult Smokers
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2019
Price : $35 *
At a glance
- Drugs Cytisine (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms ORCA-1
- Sponsors Achieve Life Sciences
- 06 Nov 2019 According to an Achieve Life Sciences media release, the company hosted its first investor day on 20th Sep 2019, featuring an updated ORCA-1 data presentation.
- 06 Nov 2019 According to an Achieve Life Sciences media release, positive efficacy and compliance results from this trial were presented at the Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference.
- 24 Oct 2019 According to an Achieve Life Sciences media release, data from this study will be presented at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History